Deutsche Bank Aktiengesellschaft »

Lenz Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2024-06-30 $92k 5.3k 17.29

More positions owned by Deutsche Bank Aktiengesellschaft

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
UnitedHealth (UNH)
Adobe Systems Incorporated (ADBE)
Qualcomm (QCOM)

View all positions for Deutsche Bank Aktiengesellschaft

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics